REQUEST A DEMO
Total
USD $0.00
Search more companies

Neupharm Sp. z o.o. (Poland)

Main Activities: All Other Professional, Scientific, and Technical Services
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | Department Stores | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Neupharm Sp. z o.o. Profile Updated: August 01, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Neupharm Sp. z o.o. is based in Poland, with the head office in Mszczonow. It operates in the All Other Professional, Scientific, and Technical Services industry. The company was established on November 21, 2017. During that time, Neupharm Sp. z o.o.’s total assets decreased by 41.51%.

Headquarters
Ul. Lugowa 85
Mszczonow; Mazowieckie; Postal Code: 96-320

Contact Details: Purchase the Neupharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Neupharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Neupharm Sp. z o.o. report to view the information.
Incorporation Date:
November 21, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Neupharm Sp. z o.o. I Wspolnicy sp. k.
Company Performance
Financial values in the chart are available after Neupharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-46.06%
Operating profit (EBIT)
-79.03%
Net Profit (Loss) for the Period
-78.13%
Total assets
-41.51%
Total equity
12.84%
Return on Equity (ROE)
-47.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?